MEDICLIN Aktiengesellschaft reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was EUR 181.11 million compared to EUR 166.75 million a year ago. Revenue was EUR 184.39 million compared to EUR 169.44 million a year ago. Net income was EUR 6.16 million compared to net loss of EUR 3.97 million a year ago. Basic earnings per share from continuing operations was EUR 0.13 compared to basic loss per share from continuing operations of EUR 0.08 a year ago. Diluted earnings per share from continuing operations was EUR 0.13 compared to diluted loss per share from continuing operations of EUR 0.08 a year ago.
For the six months, sales was EUR 355.35 million compared to EUR 323.12 million a year ago. Revenue was EUR 361.13 million compared to EUR 329.35 million a year ago. Net income was EUR 2.3 million compared to net loss of EUR 15.59 million a year ago. Basic earnings per share from continuing operations was EUR 0.05 compared to basic loss per share from continuing operations of EUR 0.33 a year ago. Diluted earnings per share from continuing operations was EUR 0.05 compared to diluted loss per share from continuing operations of EUR 0.33 a year ago.